Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis

Abstract

PurposeTo assess safety and outcome of radiofrequency ablation (RFA) and microwave ablation (MWA) as compared to systemic chemotherapy and partial hepatectomy (PH) in the treatment of colorectal liver metastases (CRLM).MethodsMEDLINE, Embase and the Cochrane Library were searched. Randomized trials and comparative observational studies with multivariate analysis and/or matching were included. Guidelines from National Guideline Clearinghouse and Guidelines International Network were assessed using the AGREE II instrument.ResultsThe search revealed 3530 records; 328 were selected for full-text review; 48 were included: 8 systematic reviews, 2 randomized studies, 26 comparative observational studies, 2 guideline-articles and 10 case series; in addition 13 guidelines were evaluated. Literature to assess the effectiveness of ablation was limited. RFA + systemic chemotherapy was superior to chemotherapy alone. PH was superior to RFA alone but not to RFA + PH or to MWA. Compared to PH, RFA showed fewer complications, MWA did not. Outcomes were subject to residual confounding since ablation was only employed for unresectable disease.ConclusionThe results from the EORTC-CLOCC trial, the comparable survival for ablation + PH versus PH alone, the potential to induce long-term disease control and the low complication rate argue in favour of ablation over chemotherapy alone. Further randomized comparisons of ablation to current-day chemotherapy alone should therefore be considered unethical. Hence, the highest achievable level of evidence for unresectable CRLM seems reached. The apparent selection bias from previous studies and the superior safety profile mandate the setup of randomized controlled trials comparing ablation to surgery.Electronic supplementary materialThe online version of this article (10.1007/s00270-018-1959-3) contains supplementary material, which is available to authorized users.

US-guided laser treatment of parathyroid adenomas

“…Prior reports have noted extremely well-defined, well-demarcated zones of ablation, based upon limited energy penetration. Thus, although these attributes of laser ablation may not be ideal for the treatment of liver metastases and have led to greater adoption of other energy sources in the liver [21][22][23][24], these very properties are likely to be more suited for parathyroid pathology.…”

How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective

“…Theoretical benefits of MWA over RFA include larger ablation zone, shorter duration, and no heat‐sink effect . There are some studies reporting the outcomes of MWA for colorectal liver metastases as a safe and effective modality for use in the treatment of CRLM patients . Correa‐Gallego et al.…”

Thermal Ablation of Metastatic Colon Cancer to the Liver

“…6 Several uncontrolled studies of TA have reported OS outcomes similar to those after surgical resection (up to 55% at 5 years). [7][8][9][10] Different TA technologies are available including radiofrequency ablation (RFA), microwave ablation (MWA), laser, and cryoablation. They all use either heat or freezing temper-atures as a mean to achieve cell damage and death of the target tumor.…”